Research map: Potent and Sustained Lowering of Serum Uric Acid by YJH ‐012‐D, a G al NA c‐Conjugated si RNA Targeting Xanthine Dehydrogenase

Back to the article

Papers in this map

  1. Therapeutic siRNA: state of the art · Bo Hu · 2020 · 1583 citations · Cited by this paper
  2. Using a N ano BRET ‐Based Ligand‐Binding Assay at the β 2 ‐Adrenoceptor for Undergraduate Pharmacology Education · 2026 · Related
  3. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout · William B. White · 2018 · 921 citations · Cited by this paper
  4. Magnitude, Preventability, and Determinants of Adverse Drug Reactions Among Hospitalized Obstetric Patients in Ethiopia: A Prospective Observational Study · 2026 · Related
  5. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics · Aaron D. Springer · 2018 · 702 citations · Cited by this paper
  6. A Prospective Study of Marsh PK ‐ PD Model and Schnider PK ‐ PD Model During Anesthesia Induction for Obese Patients Undergoing Elective Heart Surgery · 2026 · Related
  7. Hyperuricemia and its related diseases: mechanisms and advances in therapy · Lin Du · 2024 · 618 citations · Cited by this paper
  8. Reported Characteristics of Anaphylaxis Associated With Glatiramer Acetate: A Pharmacovigilance Analysis of the FDA and Canadian Databases · 2026 · Related
  9. Strategies, design, and chemistry in siRNA delivery systems · Yizhou Dong · 2019 · 583 citations · Cited by this paper
  10. Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies · 2026 · Related
  11. Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates · Jayaprakash K. Nair · 2017 · 280 citations · Cited by this paper
  12. A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese Subjects · 2026 · Related
  13. Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis · Yang Li · 2021 · 141 citations · Cited by this paper
  14. Student and Graduate Perceptions of Their Development of the Core Attitudes From the British Pharmacological Society's Undergraduate Pharmacology Curriculum · 2026 · Related
  15. Update on gout management: what is old and what is new · Yuliya Afinogenova · 2021 · 107 citations · Cited by this paper
  16. Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education · 2026 · Related
  17. Gout. Novel therapies for treatment of gout and hyperuricemia · Robert A. Terkeltaub · 2009 · 87 citations · Cited by this paper
  18. Impact of FCGR2A and FCGR3A Gene Variants on the Response to Rituximab in Patients With Glomerular Diseases · 2026 · Related
  19. Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia · Ruoyu Wang · 2022 · 77 citations · Cited by this paper
  20. The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma · 2026 · Related
  21. Hepatocyte-Specific Ablation or Whole-Body Inhibition of Xanthine Oxidoreductase in Mice Corrects Obesity-Induced Systemic Hyperuricemia Without Improving Metabolic Abnormalities · Daniel B. Harmon · 2019 · 47 citations · Cited by this paper
  22. Fatty acid oxidation-induced HIF-1α activation facilitates hepatic urate synthesis through upregulating NT5C2 and XDH · Ningning Liang · 2024 · 27 citations · Cited by this paper
  23. C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation · Yiting Wang · 2022 · 18 citations · Cited by this paper
  24. Identification of inhibitors from a functional food-based plant Perillae Folium against hyperuricemia via metabolomics profiling, network pharmacology and all-atom molecular dynamics simulations · Chuanghai Wu · 2024 · 16 citations · Cited by this paper
  25. XDH and XO Research and Drug Discovery—Personal History · Takeshi Nishino · 2023 · 13 citations · Cited by this paper
  26. The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides · Julia F. Alterman · 2026 · 1 citation · Cited by this paper
  27. Evolution of siRNA Therapeutics: From Mechanistic Foundations to Clinical Expansion · Quoc‐Viet Le · 2026 · 1 citation · Cited by this paper
  28. Untitled · Cited by this paper

Source: OpenAlex (CC0)